TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) — Read more »
Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — A Read more »
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) — Read more »
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) — Read more »
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Read more »
Soluções Edge AI DA Próxima Geração Para o Mundo Real: Navegação Autônoma para Drones, Vigilância e Robótica
IRVINE, Califórnia, June 17, 2025 (GLOBE NEWSWIRE) — A Read more »
Edge-KI-Lösungen der nächsten Generation für die reale Welt: Autonome Navigation für Drohnen, Überwachung und Robotik
IRVINE, Kalifornien, June 17, 2025 (GLOBE NEWSWIRE) — Read more »
Solutions Edge AI de pointe pour le monde réel : navigation autonome pour drones, surveillance et robotique
IRVINE, Californie, 17 juin 2025 (GLOBE NEWSWIRE) — Read more »
Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics
IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) — Read more »
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025
REGULATED INFORMATION
June 13, 2025, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »